You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ICL-670

Showing 1 - 25 of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))

Completed
Has Results
  • Thalassemia
  • Iron Overload
  • Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
  • Oakland, California
    CHRCO
Jul 20, 2021

Beta-thalassemia, Iron Overload Trial in Los Angeles, Oakland, Chicago (Deferasirox)

Completed
Has Results
  • Beta-thalassemia
  • Iron Overload
  • Los Angeles, California
  • +2 more
Jun 8, 2021

Hepatic Impairment Trial in Kiel (Deferasirox)

Completed
  • Hepatic Impairment
  • Kiel, Germany
    Novartis Investigative Site
Dec 6, 2020

ß-thalassemia, Transfusional Iron Overload Trial in Cagliari, Genova, Orbassano (Deferasirox)

Completed
  • β-thalassemia
  • Transfusional Iron Overload
  • Cagliari, CA, Italy
  • +2 more
Dec 6, 2020

High Risk MDS or AML Patients Trial in Philadelphia (Exjade® (deferasirox, ICL670))

Completed
  • High Risk MDS or AML Patients
  • Exjade® (deferasirox, ICL670)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 7, 2020

Aplastic Anemia Trial in Moscow (ICL670, Chelation, No chelation)

Terminated
Has Results
  • Aplastic Anemia
  • Moscow, Russian Federation
    Novartis Investigative Site
Jul 8, 2019

Transfusion-dependent ß-thalassemia Patients, Cardiac Iron Overload Trial in Athens, Patras (Deferasirox, Deferoxamine (DFO))

Terminated
Has Results
  • Transfusion-dependent β-thalassemia Patients
  • Cardiac Iron Overload
  • Athens, GR, Greece
  • +3 more
Oct 21, 2019

Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndrome
  • Iron Overload
  • Birmingham, Alabama
  • +47 more
Jul 21, 2021

Transfusion-dependent Hemachromatosis, Thalassemia Major, Sickle Cell Disease Trial in Boston (Deferoxamine, Deferasirox, HIDA)

Completed
Has Results
  • Transfusion-dependent Hemachromatosis
  • +2 more
  • Boston, Massachusetts
    Children's Hospital Boston
Jun 14, 2019

Non-transfusion Dependent Thalassemia Trial in Worldwide (deferasirox)

Completed
Has Results
  • Non-transfusion Dependent Thalassemia
  • Nanning, Guangxi, China
  • +10 more
Sep 19, 2019

Transfusion-dependent Iron Overload Trial in Worldwide (Deferasirox)

Completed
  • Transfusion-dependent Iron Overload
  • Adelaide, Australia
  • +97 more
Feb 8, 2020

MDS, Iron Overload Trial in Stanford, Detroit, Houston (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Iron Overload
  • Stanford, California
  • +2 more
Jun 1, 2021

MDS Trial in Worldwide (Deferasirox, Placebo)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Anaheim, California
  • +71 more
Oct 30, 2020

Binocular Vision Alternations and fMRI Activation After ICL

Recruiting
  • Binocular Vision Disorder
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center, Sun Yat-sen University
    Nov 30, 2022

    Refractive Errors, Myopia, Myopic Astigmatism Trial in Cairo (Refractive Surgery)

    Recruiting
    • Refractive Errors
    • +2 more
    • Refractive Surgery
    • Cairo, Egypt
      Alwatany Eye Hospital
    Jan 1, 2023

    Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)

    Recruiting
    • Idiopathic CD4 T Cell Lymphocytopenia
    • Gardasil 9
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 10, 2023

    Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human

    Not yet recruiting
    • Idiopathic CD4 Lymphopenia
    • Recombinant human interleukin (IL) 7-hyFc
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Recruiting
    • Idiopathic CD4-Positive
    • T-Lymphocytopenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Myopia, Myopic Astigmatism Trial in United States (EVO ICL)

    Recruiting
    • Myopia
    • Myopic Astigmatism
    • EVO ICL
    • Overland Park, Kansas
    • +6 more
    Sep 15, 2022

    Quality of Vision in Implantable Collamer Lens (ICL)

    Completed
    • Pupil Diameter
      • Shenyang, Liaoning, China
        He Eye Specialist Hospital, Shenyang.
      Jan 29, 2022

      Natural History of Idiopathic CD4+ Lymphocytopenia

      Recruiting
      • Idiopathic CD4+ Lymphocytopenia
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 18, 2022

        MDS Trial in Toronto (Deferasirox + Azacitidine, Azacitidine)

        Terminated
        • Myelodysplastic Syndromes
        • Toronto, Ontario, Canada
          Odette Cancer Centre, Sunnybrook Health Sciences Centre
        Apr 24, 2018

        Algorithm for Vertical Placement of Implantable Collamer Lens

        Recruiting
        • Myopia
        • Visian
        • Abbotsford, British Columbia, Canada
          Valley Laser Eye Centre
        Feb 22, 2022

        Myopia Trial in China (viscoelastic-free implantation system, standard viscoelastic-assisted Implantation system)

        Recruiting
        • Myopia
        • viscoelastic-free implantation system
        • standard viscoelastic-assisted Implantation system
        • Guangzhou, Guangdong, China
        • +4 more
        Oct 4, 2021

        Myopia, Myopic Astigmatism Trial in United States (EVO/EVO+ Visian ICL)

        Active, not recruiting
        Has Results
        • Myopia
        • Myopic Astigmatism
        • EVO/EVO+ Visian ICL
        • Phoenix, Arizona
        • +13 more
        Jul 1, 2022